Effects of cytoprotective antioxidants on lymphocytes from representative mitochondrial neurodegenerative diseases

被引:16
作者
Goldschmidt, Ruth
Arce, Pablo M.
Khdour, Omar M.
Collin, Valerie C.
Dey, Sriloy
Jaruvangsanti, Jennifer
Fash, David M.
Hecht, Sidney M. [1 ]
机构
[1] Arizona State Univ, Ctr BioEnerget, Biodesign Inst, Tempe, AZ 85287 USA
关键词
Adenosine triphosphate; Mitochondrial dysfunction; Antioxidants; Reactive oxygen species; Electron transport chain; ELECTRON-TRANSPORT CHAIN; FAMILIAL ALZHEIMERS-DISEASE; LEIGH-SYNDROME; OXIDATIVE-PHOSPHORYLATION; MISSENSE MUTATIONS; ENZYME-ACTIVITIES; QUINONE ANALOGS; COX DEFICIENCY; IDEBENONE; CELLS;
D O I
10.1016/j.bmc.2012.11.051
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Two new aza analogues of the neuroprotective agent idebenone have been synthesized and characterized. Their antioxidant activity, and ability to augment ATP levels have been evaluated in several different cell lines having suboptimal mitochondrial function. Both compounds were found to be good ROS scavengers, and to protect the cells from oxidative stress induced by glutathione depletion. The compounds were more effective than idebenone in neurodegenerative disease cells. These novel pyrimidinol derivatives were also shown to augment ATP levels in coenzyme Qm-deficient human lymphocytes. The more lipophilic side chains attached to the pyrimidinol redox core in these compounds resulted in less inhibition of the electron transport chain and improved antioxidant activity. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:969 / 978
页数:10
相关论文
共 63 条
  • [1] Production of reactive oxygen species in brain mitochondria: Contribution by electron transport chain and non-electron transport chain sources
    Adam-Vizi, V
    [J]. ANTIOXIDANTS & REDOX SIGNALING, 2005, 7 (9-10) : 1140 - 1149
  • [2] The expression of several mitochondrial and nuclear genes encoding the subunits of electron transport chain enzyme complexes, cytochrome c oxidase, and NADH dehydrogenase, in different brain regions in Alzheimer's disease
    Aksenov, MY
    Tucker, HM
    Nair, P
    Aksenova, MV
    Butterfield, DA
    Estus, S
    Markesbery, WR
    [J]. NEUROCHEMICAL RESEARCH, 1999, 24 (06) : 767 - 774
  • [3] A Strategy for Suppressing Redox Stress within Mitochondria
    Arce, Pablo M.
    Khdour, Omar M.
    Goldschmidt, Ruth
    Armstrong, Jeffrey S.
    Hecht, Sidney M.
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (08): : 608 - 613
  • [4] Pharmacokinetic evaluation of idebenone
    Becker, Claudia
    Bray-French, Katharine
    Drewe, Juergen
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2010, 6 (11) : 1437 - 1444
  • [5] Bergamasco B, 1994, Funct Neurol, V9, P161
  • [6] The oxidation of 2′,7′-dichlorofluorescin to reactive oxygen species:: A self-fulfilling prophesy?
    Bonini, MG
    Rota, C
    Tomasi, A
    Mason, RP
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2006, 40 (06) : 968 - 975
  • [7] Quinone analogues regulate mitochondrial substrate competitive oxidation
    Brière, JJ
    Schlemmer, D
    Chretien, D
    Rustin, P
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 316 (04) : 1138 - 1142
  • [8] Friedreich's ataxia: Autosomal recessive disease caused by an intronic GAA triplet repeat expansion
    Campuzano, V
    Montermini, L
    Molto, MD
    Pianese, L
    Cossee, M
    Cavalcanti, F
    Monros, E
    Rodius, F
    Duclos, F
    Monticelli, A
    Zara, F
    Canizares, J
    Koutnikova, H
    Bidichandani, SI
    Gellera, C
    Brice, A
    Trouillas, P
    DeMichele, G
    Filla, A
    DeFrutos, R
    Palau, F
    Patel, PI
    DiDonato, S
    Mandel, JL
    Cocozza, S
    Koenig, M
    Pandolfo, M
    [J]. SCIENCE, 1996, 271 (5254) : 1423 - 1427
  • [9] CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
  • [10] Oxidative DNA damage: mechanisms, mutation, and disease
    Cooke, MS
    Evans, MD
    Dizdaroglu, M
    Lunec, J
    [J]. FASEB JOURNAL, 2003, 17 (10) : 1195 - 1214